Skip to content
51

pantoprazol

Worth a look

Shows low returns (0.0%), but strong incumbent ratings (4.7★) keeps it on the watch list.

Market size 79Growth 20Conversion 99Competition 22Returns 100Price range 42Avg price 57Brand share 24Review moat 74Quality gap 18

Returns

Incredible0.0%

return rate — above 6% kills the launch gate

Conversion

Incredible18.6%

search→purchase rate — share of searches ending in a sale

Market size

Great€1.1M

€1.1M/yr · 463K searches

Review moat

Good542

avg incumbent reviews — the moat a new listing must climb

Avg price

Good€12.86

avg listing price — sweet spot $15–$100

Price range

Okay€5.45–€21.83

cheapest to priciest tracked listing — scored on the share inside $15–$100

Brand share

Bad91%

top-5 brand share — brand-locked demand

Competition

Bad73%

top-5 click share — a locked-up shelf

Growth

Bad-10.0%

90-day search growth — must beat 0% to launch

Quality gap

Bad4.7★

avg incumbent rating — lower means beatable quality

Competition

The top 5 products capture 73% of clicks — a locked-up shelf that new listings rarely crack.

Brands

7 falling

Sellers

24

Top-5 brand share

91%

Open market

3%

  • apo-discounter.de42%
  • Bodfeld Apotheke22%
  • 1A PHARMA10%
  • vitenda9%
  • ADGC7%
  • ratiopharm6%
  • Open — no brand owns it (1 brand, 3%)

Product shelf

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%€110K20%€221K30%€331K40%€442K101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 12 tracked products in this niche — three views at once, no toggling.

Demand & seasonality

Weekly Amazon search volume, last 104 weeks — -10.0% search growth over the last 90 days.
10K6KPrime Day '25SepDecMarJunAugNovMarMay

No pronounced peak months · busiest ÷ quietest = 1.2×